EUVIMEDEUVIMED entdecken
Crossref

Incisional PSMA PET/CT-positive recurrences in prostate cancer– is there an implication on clinical care?

Giovanni Mazzucato, Fabian Falkenbach, Jonas Ekrutt, Daniel Köhler, Gunhild von Amsberg, Maria Angela Cerruto, Alessandro Antonelli, Thomas Steuber, Markus Graefen, Tobias Maurer

Clinical & Experimental Metastasis · 2025

DOI: 10.1007/s10585-025-10331-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Metastasis, 2025. Verfasst von Giovanni Mazzucato und 9 weiteren Autor:innen. Beteiligte Einrichtung: Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Positron Emission Tomography Computed Tomography, Prostatectomy, Prostatic Neoplasms. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oligorecurrent prostate cancer (PCa) can be treated with metastasis-directed therapy (MDT), which may be performed using radioguided surgery (RGS) as an experimental approach. These procedures have shown promising outcomes, largely due to the high lesion detection rate of positron emission tomography/computed tomography (PET/CT). We present a case series of patients who underwent RGS following robot-assisted radical prostatectomy (RARP). All excised recurrences were found in unusual anatomical locations, potentially resulting from prior invasive surgical procedures. Although three out of four patients did not exhibit a reduction in prostate-specific antigen (PSA) levels post-procedure, these procedures allowed for the successful removal of tumor metastases, the exclusion of other malignancies through molecular tests, and the administration of systemic targeted therapy. Additionally, no surgical complications were reported.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm Recurrence, LocalPositron Emission Tomography Computed TomographyProstatectomyProstatic NeoplasmsAgedHumansMaleMiddle AgedGlutamate Carboxypeptidase IIProstate-Specific AntigenRobotic Surgical ProceduresAntigens, Surface

Stichwörter der Autor:innen

Biochemical recurrence (BCR)Metastasis-directed therapy (MDT)Radio guided surgery (RGS)Salvage surgery

Substanzen

Glutamate Carboxypeptidase IIProstate-Specific AntigenFOLH1 protein, humanAntigens, Surface

Autor:innen und Institutionen

  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
  • Department of Radiology and Nuclear Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. t.maurer@uke.de.

Zitieren

APA

Mazzucato, G., Falkenbach, F., Ekrutt, J., Köhler, D., von Amsberg, G., Cerruto, M. A., Antonelli, A., Steuber, T., Graefen, M., & Maurer, T. (2025). Incisional PSMA PET/CT-positive recurrences in prostate cancer– is there an implication on clinical care?. Clinical & Experimental Metastasis. https://doi.org/10.1007/s10585-025-10331-8

Vancouver

Mazzucato G, Falkenbach F, Ekrutt J, Köhler D, von Amsberg G, Cerruto MA, et al. Incisional PSMA PET/CT-positive recurrences in prostate cancer– is there an implication on clinical care?. Clinical & Experimental Metastasis. 2025. doi:10.1007/s10585-025-10331-8

BibTeX
@article{Mazzucato2025,
  author = {Mazzucato, Giovanni and Falkenbach, Fabian and Ekrutt, Jonas and Köhler, Daniel and von Amsberg, Gunhild and Cerruto, Maria Angela and Antonelli, Alessandro and Steuber, Thomas and Graefen, Markus and Maurer, Tobias},
  title = {Incisional PSMA PET/CT-positive recurrences in prostate cancer– is there an implication on clinical care?},
  journal = {Clinical & Experimental Metastasis},
  year = {2025},
  doi = {10.1007/s10585-025-10331-8}
}
Kostenlos starten →